Phylo Launches Target Atlas for Drug Target Prioritization

Sep 29, 2026
Phylo has launched Target Atlas, an AI application that collects and ranks evidence for potential drug targets. A Parkinson's edition was developed with the Michael J. Fox Foundation for Parkinson's Research.
Phylo Launches Target Atlas for Drug Target Prioritization

Phylo Inc. announced in a press release the launch of Target Atlas, an application that uses hundreds of AI agents to collect and synthesize evidence for drug target prioritization. The company says the application can reduce evidence gathering from months to days while retaining records linked to their sources.

Target Atlas assesses genetics, expression, clinical activity, safety, tractability, biomarkers, competition and published research. Scientists can change evidence weights, compare how criteria affect rankings and review target profiles through interactive charts. A free public edition is available with a Biomni account.

Phylo also developed a Parkinson's edition with the Michael J. Fox Foundation for Parkinson's Research. It combines the foundation's target prioritization framework with evidence that can be continuously updated. An enterprise edition adds private data integration, governed Biomni deployments, target pair dashboards and AI scoring.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.